Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 2021 Sep 20;59(10):e03094-20. doi: 10.1128/JCM.03094-20

Closing The Brief Case: A Variant on a Classic—Abiotrophia defectiva Endocarditis with Discitis

Rebekah E Dumm a,#, Anna Wing b,#, Aaron Richterman b, Jerry Jacob b, Laurel J Glaser a, Kyle G Rodino a,
Editor: Carey-Ann D Burnhamc
PMCID: PMC8451423  PMID: 34542328

ANSWERS TO SELF-ASSESSMENT QUESTIONS

  • 1.

    Abiotrophia defectiva grows best on which media?

    • a.

      TSA media with 5% sheep blood agar

    • b.

      MacConkey agar

    • c.

      Enriched chocolate agar

    • d.

      Columbia CNA media with 5% sheep blood agarAnswer: c. Abiotrophia defectiva grows best on enriched chocolate agar. Both Abiotrophia and Granulicatella species are fastidious organisms which require supplemental l-cysteine or pyridoxal hydrochloride for growth, both of which are absent from most routine media. Growth is not supported on sheep blood, MacConkey, or CNA agars.

  • 2.

    Abiotrophia and Granulicatella species are most reliably susceptible to which antimicrobial?

    • a.

      Vancomycin

    • b.

      Meropenem

    • c.

      Gentamicin

    • d.

      CeftriaxoneAnswer: a. Vancomycin is the most reliably susceptible antimicrobial for these species. Susceptibilities to ceftriaxone and penicillin vary significantly between Abiotrophia and Granulicatella species. While broader-spectrum drugs such as carbapenems, gentamicin, and vancomycin are more reliably effective, de-escalation to penicillin and ceftriaxone requires susceptibility testing due to the unpredictable susceptibility profiles.

  • 3.
    What is the prevalence of infective endocarditis caused by Abiotrophia and Granulicatella species?
    • a.
      <5%
    • b.
      10%
    • c.
      20%
    • d.
      >25%Answer: a. Abiotrophia and Granulicatella species are rare causes of infective endocarditis, contributing to <5% of total disease etiologies. Because they are fastidious organisms and can present as culture-negative endocarditis, their prevalence may be underestimated. The clinical presentation of endocarditis caused by Abiotrophia often includes fever, vegetations, cardiac murmur, and, occasionally, emboli.

TAKE-HOME POINTS

  • Abiotrophia and Granulicatella species (formerly termed “nutritionally variant streptococci”) have unique growth requirements and will not thrive on routine blood agar, growing best on enriched chocolate agar.

  • Abiotrophia and Granulicatella species can be distinguished from most other Streptococcus-like species by satellite growth along a staphylococcal streak. Relevant biochemical properties include lack of growth in 6.5% NaCl broth and pyrrolidonyl aminopeptidase (PYR) and leucine aminopeptidase (LAP) activity.

  • The lack of detection by rapid molecular identification platforms in conjunction with Gram stain morphology consistent with Gram-positive cocci in pairs or chains should raise suspicions for Abiotrophia and Granulicatella species.

  • Abiotrophia and Granulicatella species have variable susceptibility to penicillin and ceftriaxone, requiring antimicrobial susceptibility testing for optimal management.

See https://doi.org/10.1128/JCM.03093-20 in this issue for case presentation and discussion.

Contributor Information

Kyle G. Rodino, Email: Kyle.Rodino@pennmedicine.upenn.edu.

Carey-Ann D. Burnham, Washington University School of Medicine


Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES